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Identification of Uncommon Recurrent Potocki-Lupski
Syndrome-Associated Duplications and the Distribution
of Rearrangement Types and Mechanisms in PTLS
Feng Zhang,1,8 Lorraine Potocki,1,3 Jacinda B. Sampson,4 Pengfei Liu,1 Amarilis Sanchez-Valle,1
Patricia Robbins-Furman,1 Alicia Delicado Navarro,5 Patricia G. Wheeler,6 J. Edward Spence,7
Campbell K. Brasington,7 Marjorie A. Withers,1 and James R. Lupski1,2,3,*
Nonallelic homologous recombination (NAHR) can mediate recurrent rearrangements in the human genome and cause genomic disor-
ders. Smith-Magenis syndrome (SMS) and Potocki-Lupski syndrome (PTLS) are genomic disorders associated with a 3.7 Mb deletion and
its reciprocal duplication in 17p11.2, respectively. In addition to these common recurrent rearrangements, an uncommon recurrent
5 Mb SMS-associated deletion has been identiﬁed. However, its reciprocal duplication predicted by the NAHR mechanism had not
been identiﬁed. Here we report the molecular assays on 74 subjects with PTLS-associated duplications, 35 of whom are newly investi-
gated. By both oligonucleotide-based comparative genomic hybridization and recombination hot spot analyses, we identiﬁed two cases
of the predicted 5 Mb uncommon recurrent PTLS-associated duplication. Interestingly, the crossovers occur in proximity to a recently
delineated allelic homologous recombination (AHR) hot spot-associated sequence motif, further documenting the common hot spot
features shared between NAHR and AHR. An additional eight subjects with nonrecurrent PTLS duplications were identiﬁed. The smallest
region of overlap (SRO) for all of the 74 PTLS duplications examined is narrowed to a 125 kb interval containing only RAI1, a gene
recently further implicated in autism. Sequence complexities consistent with DNA replication-based mechanisms were identiﬁed in
four of eight (50%) newly identiﬁed nonrecurrent PTLS duplications. Our ﬁndings of the uncommon recurrent PTLS-associated dupli-
cation at a relative prevalence reﬂecting the de novo mutation rate and the distribution of 17p11.2 duplication types in PTLS reveal
insights into both the contributions of newmutations and the different underlying mechanisms that generate genomic rearrangements
causing genomic disorders.Potocki-Lupski syndrome (PTLS [MIM 610883]) is a
recently recognized, 17p11.2 duplication-associated con-
dition with clinical features including infantile hypotonia,
failure to thrive, mental retardation, autism, behavioral
abnormalities, sleep apnea, and structural cardiovascular
anomalies.1,2 The 3.7 Mb common type of PTLS-associated
duplication is reciprocal to a common 17p11.2 deletion
observed in association with Smith-Magenis syndrome
(SMS [MIM 182290]).3 Our previous molecular studies
demonstrated that these commonduplication anddeletion
rearrangements are caused by the nonallelic homologous
recombination (NAHR) between the paralogous sequence
repeats, distal and proximal SMS-REPs (Figure 1).4–6 These
long (>200 kb) repeat sequences with high similarity
(>97%), i.e., low-copy repeats (LCRs) or segmental duplica-
tions (SDs), are vulnerable to NAHR.7–9 NAHR between
direct LCRs or SDs can lead to reciprocal deletion and dupli-
cation, whereas inversion of a genomic segment can occur
when ﬂanking inverted LCRs act as substrates.7,8 NAHR-
associated events can result in recurrent rearrangements
with a common size and clustered breakpoints.8
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susceptible to genomic instability and genomic rearrange-
ments.10 In addition to the common deletion and duplica-
tion rearrangements associated with SMS and PTLS, respec-
tively, another recurrent 17p deletion that occurs less
frequently than the common SMS deletion, i.e., an
uncommon recurrent SMS deletion, has been observed to
result from NAHR utilizing alternative LCR substrates
LCR17pA and LCR17pD (Figure 1).11,12 The NAHR mecha-
nism predicts a reciprocal duplication to this uncommon
recurrent SMS deletion. Interestingly, evidence from
sperm-based assays has revealed that this uncommon
recurrent 17p duplication occurs de novo at a frequency
of 8.74 3 107 in male gametes,13 suggesting its potential
existence in live-born individuals. However, this speciﬁc
duplication type, which is uncommon but predicted to
be recurrent, has never been detected in the PTLS subjects
of our previous investigations or in those of other groups.
In this study we report two subjects with the uncommon
recurrent PTLS duplication, demonstrate the anticipated
NAHR mechanism, show the proximity of the speciﬁc
strand exchanges to a recently described homologous
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Figure 1. Identification of Two 5 Mb Uncommon
Recurrent PTLS-Associated Duplications
High-resolution oligonucleotide aCGH analyses re-
vealed the recurrent SMS- and PTLS-associated rear-
rangements mediated by NAHR between the LCRs
on 17p. The following abbreviations are used: dele-
tion, del; duplication, dup. The green (loss), black
(no change), and red (gain) dots show the relative
intensities in log2ratio (deviation from horizontal
line of zero) and genomic locations of the oligonu-
cleotide probes employed in our aCGH assay.
The regions that lack unique probes correspond to
the LCRs. The 3.7 Mb common rearrangements are
mediated by the distal and proximal SMS-REPs de-
picted on the horizontal black lines representing
proximal chromosome 17p, whereas the recombina-
tions between LCR17pA and LCR17pD lead to the
5 Mb uncommon recurrent rearrangements. The
regions with copy number gains are indicated with
red horizontal bars, and the losses are shown in
green. The known copy number polymorphisms
are indicated by arrows.distribution and type of PTLS-associated duplications, and
furthermore glean insights into the contribution of de
novo mutations and different rearrangement mechanisms
to genomic disorders.
Identiﬁcation of 5 Mb Uncommon Recurrent
PTLS-Associated Duplication
To investigate the hypothesis that the reciprocal duplica-
tion to the uncommon recurrent SMS deletion can also
lead to PTLS and to study the size distribution of the
PTLS-associated duplications in 17p, we designed a high-
density oligonucleotide-based microarray for comparative
genomic hybridization (CGH) assay to ﬁnely examine
the location, size, genomic content, and breakpoint
interval of the PTLS-associated 17p rearrangements. This
array is based on the Agilent 4 3 44K format. Approxi-
mately 44,000 oligonucleotide probes were selected from
the Agilent eArray system to interrogate the entire 17p
with a genome resolution of ~500 bp. Probes having
similar sequences in other genomic loci had been ﬁltered
out, and only unique probes were employed. The female
control DNA (NA15510) was obtained from Coriell Cell
Repositories. All other experimental details are described
in our previous study.14 PTLS samples and their parental
DNAs were obtained with informed consent approved by
the Institutional Review Board for Human Subject
Research at Baylor College of Medicine.
Using the high-resolution array CGH (aCGH) assay in 35
newly sampled PTLS subjects with 17p duplications, weThe American Journal ofidentiﬁed two subjects (2808 and 2959) with
copy number gain of the 5 Mb region located
between LCR17pA and LCR17pD. These ﬁnd-
ings are consistent with the predicted
uncommon recurrent 17p duplication (Fig-
ure 1). This duplicated region includes the
RAI1 (retinoic acid inducible 1 [MIM 607642])gene that is responsible for SMS, as evidenced by deletion
mapping,15 and loss-of-function point mutations in non-
deletion patients.16 RAI1 is also considered to be the prime
candidate dosage-sensitive gene causing PTLS, based upon
mouse experiments that rescue themajority of the duplica-
tion-associated phenotype by restoring this gene to
disomic (n ¼ 2) copy number in the segmental trisomy
model.17 This interval also encompasses the entire
3.7 Mb region of the common PTLS duplication (Figure 1).
NAHR Hot Spot Analyses of Uncommon Recurrent
PTLS-Associated Duplication
Recurrent deletion and duplication rearrangements result
fromNAHRbetween LCR substrate pairs.7,8 Notably, NAHR
strand exchanges are not randomly distributed across the
homologous LCR regions but occur predominantly within
a short interval, i.e., recombination hot spots exist in
LCRs.18,19 NAHR hot spots have been identiﬁed in various
disease-associated recurrent rearrangements, such as NF1
(MIM 162200) microdeletion,20 CMT1A (MIM 118220) re-
arrangements,21,22 and common recurrent SMS and PTLS
rearrangements.3 Our previous study of six uncommon
recurrent SMS deletions also identiﬁed a strand exchange
hot spot between LCR17pA and LCR17pD.12 To investigate
whether a recombination hot spot exists in the NAHR
events that result in the uncommon recurrent PTLS dupli-
cation, we conducted further molecular assays in both
subjects identiﬁed in this study to have this duplication
type.Human Genetics 86, 462–470, March 12, 2010 463
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Figure 2. Recombination Hot Spot Anal-
yses of Uncommon Recurrent PTLS-Associ-
ated Duplications
(A) The PCR assay of the recombination
hot spot in LCR17pA (blue) and LCR17pD
(yellow). The ~630 bp crossover interval
fragment (D-A) of the recombinant
LCR17pD and LCR17pA in the 5 Mb
uncommon recurrent PTLS duplication
was ampliﬁed by using LCR-speciﬁc pri-
mers (DF, forward primers in LCR17pD;
AR, reverse primers in LCR17pA). This
assay is positive in PTLS subjects 2808
and 2959 but negative in their parents
and the control (NA 15510).
(B) Sequence analysis of the recombination
hot spot in LCR17pA and LCR17pD. The
paralogous sequence variations (PSVs)
between these two LCRs are represented
by the capital letters between colored
bars.12 The polymorphic nucleotide (SNP)
is shown by the lowercase letter. In the PCR assay with the LCR-speciﬁc primers (DF2 and AR2),13 the recombination hot spot has
been narrowed from 124 kb down to 570 bp, within which the 13-mer recombination hot spot sequence motif (CCNCCNTNNCCNC,
black)24 was found. Asterisks indicate the newly investigated uncommon recurrent duplications (red) and deletion (green) whose strand
exchanges have been further located within smaller intervals by sequencing analysis: 46 bp in subject 2808 and 359 bp in subjects 2959
and 547. The crossover intervals of our previously reported uncommon recurrent SMS deletions (green, no asterisk)12 are also shown.The lengths of the LCR17pA and LCR17pD are 124 kb of
98.6% DNA sequence identity.10,12 However, our previous
studies in the six uncommon recurrent SMS deletions
showed that the recombination events between LCR17pA
and LCR17pD occur at a hot spot within a small 524 bp
region.12 We employed the LCR-speciﬁc primers13 to
amplify the crossover interval of the hypothesized
uncommon recurrent PTLS duplication hot spot (Fig-
ure 2A). To increase ampliﬁcation speciﬁcity, Turner et al.
set a mismatch nucleotide adjacent to the 30 end of each
primer.13 Because of the low ampliﬁcation efﬁciency of
mismatch primers, two rounds of PCR ampliﬁcations
were conducted.13 Primers LCR17 DF1 and AR1 were
used for initial PCR ampliﬁcation in this study, and primers
LCR17 DF2 and AR2 were used in the nested PCR ampliﬁ-
cation. The PCR assays were repeated at least three times
to conﬁrm the consistency of the speciﬁc ampliﬁcation
results. As anticipated, the ~630 bp PCR product of the
recombination interval that is speciﬁc to the strand
exchange for the uncommon recurrent PTLS duplication
was obtained only in subjects 2808 and 2959 and not in
their parental DNAs or in the unrelated negative control
(Figure 2A). A positive control for template ampliﬁcation
in a multiplex PCR assay demonstrated the presence of
subject DNA (Figure S1). The LCR-speciﬁc PCR assay
located the recombination sites within a small hot spot
interval of 570 bp (Figure 2B). Direct DNA sequence anal-
ysis of the recombinant amplicon, and evaluation of the
paralogous sequence variants (PSVs) speciﬁc to either
LCR17pA or LCR17pD, enabled further narrowing of the
strand exchange accompanying the NAHR event. Using
this strategy to analyze the crossovers, we further reﬁned
the NAHR strand exchanges into smaller intervals of
46 bp in subject 2808 and 359 bp in subject 2959
(Figure 2B). Notably, the rearrangement in subject 2959464 The American Journal of Human Genetics 86, 462–470, March 1shared its crossover interval with one newly identiﬁed
(subject 547) and four previously identiﬁed (subjects 266,
279, 475, and 1939) uncommon recurrent SMS deletions
(Figure 2B).12 The strand exchanges in the remaining two
uncommon recurrent SMS deletions (subjects 147 and
1153) of our previous study12 were located with a 134 bp
interval adjacent to those identiﬁed in uncommon recur-
rent PTLS duplication (Figure 2B).
It has been hypothesized that allelic homologous recom-
bination (AHR) and NAHR share some common
features.18,19,21,23 Recently, a 13-mer sequence motif,
CCNCCNTNNCCNC, was delineated to be associated
with AHR hot spots24 and to be bound by PRDM9,
a zinc-ﬁnger protein involved in histone H3 lysine 4 trime-
thylation.25–27 Interestingly, we identiﬁed this speciﬁc
motif within the above 570 bp NAHR hot spot of the
uncommon recurrent types of PTLS duplication and also
SMS deletions (Figure 2B). The combined data from the
analyses of both uncommon recurrent PTLS duplication
and uncommon recurrent SMS deletion crossovers
showed that the strand exchanges occurred on either
side and within 400 bp of the hot spot motif. Our observa-
tions suggest that this AHR hot spot motif is also in
proximity to the strand exchange during NAHR. These
ﬁndings support the contention that NAHR and AHR hot
spots may be coincident and, as anticipated, that both
HR types can be stimulated by the 13-mer HR hot spot
motif.
Our observations from oligonucleotide aCGH and
recombination hot spot analyses conﬁrm that the two
5 Mb duplications indeed represent both the predicted
uncommon recurrent PTLS duplications (i.e., the recip-
rocal rearrangement to uncommon recurrent SMS dele-
tion) and the underlying NAHR mechanism through
utilization of the known recombination hot spot.2, 2010
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Figure 3. Size Distribution of the PTLS-
Associated Duplication Types
The size and genomic content of 74 PTLS-
associated 17p rearrangements are shown.
Duplicated intervals are shown as red hori-
zontal bars. Above, for reference, is a 17p
karyogram and a horizontal line showing
the short arm of chromosome 17 with
cytogenetic bands depicted above and
Mb genomic coordinates below. The open
circle denotes the centromere. To the left
are laboratory identiﬁcation numbers.
The recurrent duplications, both common
and uncommon (shown in red), include:
(1) the 3.7 Mb common type between
distal and proximal SMS-REPs and (2) the
5 Mb uncommon type between LCR17pA
and LCR17pD, shown between black
vertical dashed lines. Out of these 50
common PTLS duplications, 25 have
been described previously.1,5,14,28,44–47 In
this study, 25 common PTLS duplications
are newly reported, including 2578, 2581,
2592, 2597, 2603, 2634, 2671, 2692,
2708, 2718, 2724, 2728, 2738, 2745,
2748, 2758, 2767, 2789, 2948, 2950,
2953, 2956, 2962, 2995, and 2998. The
nonrecurrent PTLS rearrangements have
variable duplication sizes (from 0.41 to
~13.3 Mb). Twelve out of 22 nonrecurrent
PTLS rearrangements have complexities,
i.e., additional duplication, triplication
(blue), and/or deletion (green). The small-
est region of overlap (SRO; gray vertical
bar) of all of these 74 PTLS rearrangements
is 125 kb, which includes the RAI1 gene
only. The previous studies ascertaining
the PTLS-associated rearrangements by
conventional cytogenetic or molecular
assays are cited.1,5,14,28,44–52The Size Distribution, Contribution of Different
Rearrangement Mechanisms, and Smallest Region of
Overlap of the Duplications Causing PTLS
In this study,we performedmolecular analyses on35newly
ascertained subjects with PTLS-associated duplications. In
addition to the above two 5 Mb uncommon recurrent
duplications, we also detected 25 common PTLS duplica-
tions of 3.7 Mb and 8 nonrecurrent duplications with
continuous copy number gain ranging in genomic size
from0.41 to 13.3Mb (Figure 3). Together with our 39 previ-
ously reported PTLS duplications,1,14,28 aggregate data from
subjects with PTLS caused by 17p rearrangements represent
a total of 74 cases, among which 50 (67.6%) are common
recurrent, 2 (2.7%) are uncommon recurrent duplications,
and 22 (29.7%) are nonrecurrent duplications (Figure 3).
Thus, approximately 70% of PTLS duplications are recur-
rent and occur by the NAHR mechanism.
Evaluation of the size distribution and the genomic
content of the PTLS duplications, especially the nonrecur-
rent ones with variable sizes, enables ‘‘duplication
mapping’’ and helps to determine whether a ‘‘smallest
region of overlap’’ (SRO) exists that potentially containsThe Amerigene(s) contributing to the PTLS phenotype. In our
previous study on 35 PTLS subjects, the SRO was 1.3 Mb
in length, including RAI1 and 16 other genes (TNFRSF13B
[MIM 604907], MPRIP [MIM 612935], PLD6, FLCN [MIM
607273], COPS3 [MIM 604665], NT5M [MIM 605292],
MED9 [MIM 609878], RASD1 [MIM 605550], PEMT
[MIM 602391], SREBF1 [MIM 184756], TOM1L2,
LRRC48, ATPAF2 [MIM 608918], C17orf39, DRG2 [MIM
602986], and MYO15A [MIM 602666]).1 With the aid of
eight new nonrecurrent PTLS duplications identiﬁed in
this study, the SRO has been narrowed to a genomic
interval of only 125 kb (from 17,510k to 17,635k on
human chromosome 17, NCBI build 36). Notably, RAI1
is the only gene included within this 125 kb SRO, which
supports the hypothesis that, similar to the role of RAI1
deletion in SMS, the dosage-sensitive gene RAI1 is likely
to be responsible for the predominant clinical features of
the PTLS phenotype associated with 17p11.2 duplications.
This contention is also supported by mouse studies
wherein animal models of Rai1 duplication recapitulate
some physical and neurobehavioral features seen in PTLS
subjects.17can Journal of Human Genetics 86, 462–470, March 12, 2010 465
Table 1. Clinical Features of Uncommon Recurrent PTLS Duplications and Small PTLS Duplications
Trait
Uncommon Recurrent Small (<1 Mb) Duplication
2808 2959 2811 2933 2986
Sex F F M M F
Age (years) 40 7 3 8 9
Duplication size (Mb) ~5.0 ~5.0 ~0.8 0.49 0.41
Birth History
Normal growth measurements* þ þ þ NK þ
Medical and Developmental History
Poor feeding as infant* þ þ þ NK 
Failure to thrive* þ þ þ NK 
Hypotonia as infant* NK þ þ NK þ
Developmental delay*  þ þ þ þ
Epilepsy     
Subjective sleep disturbance  þ þ þ þ
Neuropsychiatric and Behavior History
Cognitive impairment* þ þ þ þ þ
Autistic featuresa,* þ  þ þ 
Hyperactivity* þ þ þ þ 
Negative behaviorsb,* þ þ þ þ þ
Diagnostic Evaluations
Sleep apnea (sleep study)* NK NK NK NK 
Ophthalmic or vision abnormality* þ þ NK  
Scoliosis > 10 degreesc     
Cardiovascular abnormalityd     NK
Structural renal anomalye þ NK NK  NK
Hearing impairmente  NK NK  
Structural CNS abnormalityf     
The following abbreviations are used: þ, feature is present; , feature is not present; NK, not known; *, feature observed in over 70% of PTLS subjects with the
common duplication.
a E.g., stereotypical or repetitive motor mannerisms, impaired social interaction.
b E.g., anxiety, withdrawal, aggression.
c ~60% of PTLS subjects with the common duplication have >10 degrees of scoliosis on diagnostic imaging.
d ~45% of PTLS subjects with the common duplication have either structural cardiovascular malformations and/or dilatation of the aortic root.
e Fewer than 10% of PTLS subjects with the common duplication have hearing impairment or structural renal anomalies.
f Structural CNS abnormalities have not been systematically evaluated by cranial imaging in our PTLS cohort.Clinical Features Associated with Uncommon
Recurrent and Small RAI1 Duplications
Similar to the clinical consequences of the common
17p11.2 rearrangements (SMS-associated deletion versus
reciprocal PTLS-associated duplication), the reciprocal
duplication to uncommon recurrent SMS-associated dele-
tion can also lead to PTLS (Table 1; Figure 4). The clinical
features observed in over 70% of individuals with the
common recurrent PTLS duplication1,2 and also observed
in the two individuals with the uncommon recurrent
duplication (subjects 2808 and 2859) include poor feeding
as infants, failure to thrive, cognitive impairment, hyper-466 The American Journal of Human Genetics 86, 462–470, March 1activity, and negative behaviors. This is perhaps expected
because the 5 Mb genomic region duplicated in the
uncommon recurrent rearrangement completely encom-
passes the 3.7 Mb common recurrent interval. Although
the case numbers (n ¼ 2) are small, there were no speciﬁc
additional clinical features delineated in the subjects
with the larger duplication.
Three of the individuals in this study (subjects 2811,
2933, and 2986) had simple 17p11.2 duplications of
<1 Mb in size (i.e., involving RAI1 and less additional
genomic content than the common PTLS duplication)
(Figure 3). Importantly, these subjects did not have2, 2010
Figure 4. Facial Features of the PTLS Subjects with Uncommon
Recurrent Duplication and Small Duplication Types
(A) Subject 2808 (uncommon recurrent), age 40 years.
(B) Subject 2959 (uncommon recurrent), age 7 years.
(C) Subject 2811 (small), age 3 years.
(D) Subject 2933 (small), age 8 years.
The facial features are not strikingly dysmorphic, yet these
subjects have similar facial features, including broad forehead,
mildly down-slanting palpebral ﬁssures, hypoplastic alae nasi
with a long nasal tip that extends below the level of the nares,
a relatively smooth philtrum, and mild micrognatia. Ears are nor-
mally set and formed, and the head circumference is normal in
each subject. Epicanthal folds are present in subjects 2959 and
2811 (unilaterally).a phenotype distinct from PTLS (Table 1). Furthermore,
these three subjects with the smaller deletions all displayed
both the behavioral phenotypes and facial gestalt observed
in PTLS patients that have the common 3.7 Mb duplica-
tion2 and those with the uncommon recurrent 5.0 Mb
duplication (Table 1; Figure 4). These observations support
the contention that RAI1 and surrounding regulatory
sequences are, more likely than the other genomic content
in the 3.7 Mb common PTLS genomic interval, responsible
for the predominant clinical features observed in PTLS.
Autism is an endophenotype that can be observed in
PTLS subjects with the common duplication.1 Such autistic
features can also be observed in other RAI1 duplication
types, including uncommon recurrent PTLS duplication
and especially the small duplications involving RAI1 re-
ported in this study. Interestingly, a recent genetic study
of autism spectrum disorder (ASD [MIM 209850]) by
gene network analysis has identiﬁed RAI1 as the most
signiﬁcant candidate gene for susceptibility to autism.29
These observations indicate a potential role for RAI1 in
the development of autism spectrum disorder.
The facial features of individuals with PTLS are shown in
Figure 4. Detailed clinical information for the PTLS
subjects is also provided as Supplemental Data available
online: uncommon recurrent PTLS duplications (Table S1)
and small simple PTLS duplications (Table S2).The AmeriIdentiﬁcation of Complex PTLS Rearrangements
In this study, we identiﬁed four (50%) complex 17p rear-
rangements in eight newly sampled nonrecurrent PTLS
duplications (Figure 3), an observation that is similar to
the complexity frequency (8 of 14, 57%) reported in our
previous study.14 Interestingly, in addition to the complex
rearrangement mapped within 17p, extra copy number
changes were identiﬁed in subjects 2714 (a 140 kb pater-
nally inherited duplication in 18p11.22, whereas the
complex rearrangement of 17p was maternally inherited)
and 2790 (a 4.1 Mb duplication in 17q23; parental origin
is not available) (data not shown).
Various DNA replication-based mechanisms (reviewed
in our previous work30,31), including FoSTeS and/or
MMBIR,14,32–34 have been shown to be involved in the
generation of rearrangement complexities. FoSTeS and
MMBIR involve serial template switching that is facilitated
by DNA annealing and priming via microhomologies at
joinpoints or breakpoints.14,31,32 The MMBIR mechanism
is proposed as a means to metabolize one-ended, double-
stranded DNA generated by collapsed DNA replication
forks,33 distinct from two-ended, double-stranded DNA
generated by double-strand breaks. Microhomology at
joining point and complexity are the hallmarks of DNA
replication-based mechanisms.31
In this study, we performed breakpoint analyses to
examine for the potential microhomology legacy of DNA
replication-based rearrangement events in the complex
PTLS duplications. We successfully ampliﬁed one break-
point interval in both subjects 2714 and 2790 and
analyzed their breakpoint sequences. In subject 2714, ami-
crohomology of 33 bp shared between two AluY elements
was detected (Figure S2), which is consistent with
Alu-Alu-mediated recombination35–37 and/or DNA replica-
tion-based mechanisms,31 though the feature of rearrange-
ment complexity in 2714 is more parsimonious with the
latter. In one breakpoint of 2790 (Figure S2), an additional
CTTT insertion consistent with the information scar of the
potential nonhomologous end-joining mechanism3,38 can
alternatively be copied from the template TTCTTTCA,
which is just 4 bp adjacent to the insertion position, bymi-
crohomologies TTand CA via the serial replication slippage
(SRS) model39–41 or other replication-based mecha-
nisms,31,42 including FoSTeS and/or MMBIR.32 These
observations from the breakpoint sequence analyses are
consistent with replication-based mechanisms underlying
complex genomic rearrangements.
Relative SMS and PTLS Disease Prevalence Reﬂects
De Novo Mutation Rates
Pooled sperm PCR studies of NAHR-mediated recurrent re-
arrangements have shown that the deletion to duplication
ratio of their mutation rates are ~2:1 for the autosomal loci
examined, reﬂecting the lack of duplication product in the
intrachromatid NAHR events.13 Therefore, considering the
low frequency (7 of 122, 5.74%; unpublished data) of
uncommon recurrent deletion in SMS-associated 17pcan Journal of Human Genetics 86, 462–470, March 12, 2010 467
rearrangements, the uncommon recurrent PTLS duplica-
tion is predicted to occur less than 5.74% of the time
because the de novo mutation rate is ~50% of that of the
deletion.13 In this study, 2.7% of PTLS-associated duplica-
tions (2 of 74) are reported to be uncommon recurrent.
Thus, the relative SMS-associated uncommon recurrent
deletion (7 of 122, data not shown) to PTLS-associated
uncommon recurrent duplication ratio of rearrangement
prevalence is 2.12. This is in close agreement with the dele-
tion-duplication (del-dup) ratio of 2.14 for the de novo
formation rate for the uncommon recurrent 17p rearrange-
ments as determined by pooled sperm assays.13Conclusions
In this study, we identify the previously predicted
uncommon recurrent PTLS-associated duplications. The
recombination hot spot analyses showed that, as predicted
by the NAHR mechanism, the two uncommon recurrent
duplications share the same recombination hot spot with
their reciprocal SMS-associated deletions.12 Moreover, the
NAHR strand exchanges occur in proximity to a recently
delineated AHR hot spot motif,24 which supports the
contention of common features and likely commonmech-
anism shared by AHR and NAHR.
The relative disease prevalence of the deletion to duplica-
tion ratio (~2:1) for the uncommon recurrent rearrange-
ments, observed respectively in SMS and PTLS subjects,
reﬂects the experimentally determined del-dup ratio of the
denovoNAHR rearrangement rate in human sperm.13 These
observations suggest that there are little, if any, rearrange-
ment-speciﬁc selective pressures acting prior to birth and
that de novo mutation and the NAHRmechanism play crit-
ical roles in underlying the recurrent rearrangements in the
humangenome that are responsible for genomicdisorders.43
By identifying more nonrecurrent PTLS duplications, we
reﬁne the SRO of PTLS duplications from 1.3Mb to approxi-
mately 125 kb and demonstrate that RAI1 is the only gene
whose copy number is altered in the 17p rearrangements of
all the PTLS subjects in this study. These ﬁndings support
the contention that RAI1 is likely the predominant gene
responsible for thePTLSphenotype.Ofnote, themost prom-
inent shared phenotypic features in subjects with the small-
estduplicationsare thebehavioralﬁndingscommontoPTLS.
Breakpoint studies in the PTLS subjects with nonrecur-
rent rearrangements reveal further complexities and
conﬁrm a prominent role for DNA replication-basedmech-
anisms in such rearrangements.Supplemental Data
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